These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25443338)

  • 1. Overcoming the roadblocks in hepatitis C virus infection.
    Baumert TF; Zeuzem S
    J Hepatol; 2014 Nov; 61(1 Suppl):S1-2. PubMed ID: 25443338
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunology of hepatitis C virus infections.
    Spaan M; Janssen HL; Boonstra A
    Best Pract Res Clin Gastroenterol; 2012 Aug; 26(4):391-400. PubMed ID: 23199499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C in dialysis units: the Saudi experience.
    Karkar A
    Hemodial Int; 2007 Jul; 11(3):354-67. PubMed ID: 17576302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus--biology, host evasion strategies, and promising new therapies on the horizon.
    Qureshi SA
    Med Res Rev; 2007 May; 27(3):353-73. PubMed ID: 16958135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recommendations for the treatment of chronic genotype 1 hepatitis C virus infection].
    Silva MO; Ridruejo E; Galdame O; Bessone F; Colombato L; Daruich J; Fainboim H; Fassio E; Fay F; Frider B; Gadano A; Galoppo MC; González J; Tanno H; Terg R; Villamil F; ;
    Acta Gastroenterol Latinoam; 2012 Sep; 42(3):234-49. PubMed ID: 23214356
    [No Abstract]   [Full Text] [Related]  

  • 6. [Epidemiology of hepatitis C and vaccine perspectives].
    Nau JY
    Rev Med Suisse; 2016 Jan; 12(503):234-5. PubMed ID: 26939196
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis C virus. Preface.
    Reddy KR; Kaplan DE
    Clin Liver Dis; 2008 Aug; 12(3):xiii-xiv. PubMed ID: 18625424
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis C Virus-Associated Non-Hodgkin Lymphomas: Biology, Epidemiology, and Treatment.
    Pozzato G; Mazzaro C; Gattei V
    Clin Liver Dis; 2017 Aug; 21(3):499-515. PubMed ID: 28689589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host-targeting agents for prevention and treatment of chronic hepatitis C - perspectives and challenges.
    Zeisel MB; Lupberger J; Fofana I; Baumert TF
    J Hepatol; 2013 Feb; 58(2):375-84. PubMed ID: 23041307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Present and future therapy for hepatitis C virus.
    Cornberg M; Deterding K; Manns MP
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):781-93. PubMed ID: 17140355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pioneering a Global Cure for Chronic Hepatitis C Virus Infection.
    Vilarinho S; Lifton RP
    Cell; 2016 Sep; 167(1):12-15. PubMed ID: 27634325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical development of TLR ligands as drugs for the treatment of chronic viral infections.
    Zhang X; Kraft A; Broering R; Schlaak JF; Dittmer U; Lu M
    Expert Opin Drug Discov; 2012 Jul; 7(7):597-611. PubMed ID: 22607384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A summary of the 20th International Symposium on Hepatitis C Virus and Related Viruses.
    Beard MR; Ffrench R; Gowans EJ; Helbig KJ; Eyre NM; Douglas MM; Grebely J; Ahlenstiel G; Locarnini S; George J; Shackel NA; White PA; Thompson AJ; Drummer HE
    Gastroenterology; 2014 Jul; 147(1):e1-4. PubMed ID: 24861641
    [No Abstract]   [Full Text] [Related]  

  • 14. NK cells prevalence, subsets and function in viral hepatitis C.
    Zeromski J; Mozer-Lisewska I; Kaczmarek M; Kowala-Piaskowska A; Sikora J
    Arch Immunol Ther Exp (Warsz); 2011 Dec; 59(6):449-55. PubMed ID: 21972016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious diseases. Hard-won advances spark excitement about hepatitis C.
    Crabb C
    Science; 2001 Oct; 294(5542):506-7. PubMed ID: 11641482
    [No Abstract]   [Full Text] [Related]  

  • 16. Innate and adaptive immune responses in HCV infections.
    Heim MH; Thimme R
    J Hepatol; 2014 Nov; 61(1 Suppl):S14-25. PubMed ID: 25443342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of antiviral therapy in Egyptian Hepatitis C Virus (HCV) genotype 4 patients with advanced liver fibrosis.
    el-Khattib AA; Abdelhakam SM; Ghoraba DM; Ibrahim WA; Sayed MM
    Eur J Intern Med; 2012 Jan; 23(1):e34-5. PubMed ID: 22153547
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatitis C in the elderly: a multicentre cross-sectional study by the Italian Association for the Study of the Liver.
    Gramenzi A; Conti F; Cammà C; Grieco A; Picciotto A; Furlan C; Romagno D; Costa P; Rendina M; Ancarani F; Chiaramonte M; Verucchi G; Craxì A; Bernardi M; Andreone P;
    Dig Liver Dis; 2012 Aug; 44(8):674-80. PubMed ID: 22538206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance duration as a predictor of sustained viral response in patients with chronic hepatitis C virus genotype 1.
    Shenoy M; Levin J; Said A; Striker R
    J Infect Dis; 2005 Jun; 191(11):1993-5; 1995-6. PubMed ID: 15871137
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapid virological response in hepatitis C virus genotype 1 and early ribavirin exposure.
    Dai CY; Chuang WL; Huang JF; Hsieh MY; Yu ML
    Hepatology; 2008 Aug; 48(2):692-3; author reply 693-4. PubMed ID: 18666250
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.